Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cemiplimab (REGN2810), in Treating Refractory Microsatellite Stable Colorectal Cancer

Clinical trial NCT07147231 · RECRUITING

Trial details

NCT number: NCT07147231
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Colorectal Adenocarcinoma Refractory Colorectal Adenocarcinoma Stage III Colorectal Cancer AJCC v8 Stage IV Colorectal Cancer AJCC v8 Unresectable Colorectal Adenocarcinoma

Start date: 2026-08-10
Primary completion: 2027-09-30
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.